JP2009506044A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009506044A5 JP2009506044A5 JP2008528086A JP2008528086A JP2009506044A5 JP 2009506044 A5 JP2009506044 A5 JP 2009506044A5 JP 2008528086 A JP2008528086 A JP 2008528086A JP 2008528086 A JP2008528086 A JP 2008528086A JP 2009506044 A5 JP2009506044 A5 JP 2009506044A5
- Authority
- JP
- Japan
- Prior art keywords
- medicament
- subject
- rosehips
- inflammatory response
- modulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000078534 Vaccinium myrtillus Species 0.000 claims 12
- 239000003814 drug Substances 0.000 claims 12
- 230000028709 inflammatory response Effects 0.000 claims 9
- 235000018811 Aframomum Nutrition 0.000 claims 6
- 241001127758 Aframomum Species 0.000 claims 6
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims 6
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims 6
- 230000015572 biosynthetic process Effects 0.000 claims 6
- 235000021029 blackberry Nutrition 0.000 claims 6
- 235000021014 blueberries Nutrition 0.000 claims 6
- 239000005550 inflammation mediator Substances 0.000 claims 6
- 238000004519 manufacturing process Methods 0.000 claims 6
- 238000003786 synthesis reaction Methods 0.000 claims 6
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims 3
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims 3
- 235000015872 dietary supplement Nutrition 0.000 claims 3
- 235000021283 resveratrol Nutrition 0.000 claims 3
- 229940016667 resveratrol Drugs 0.000 claims 3
- 108010002352 Interleukin-1 Proteins 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71073005P | 2005-08-23 | 2005-08-23 | |
| PCT/US2006/032847 WO2007024901A1 (en) | 2005-08-23 | 2006-08-23 | Cytokine modulators and related methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009506044A JP2009506044A (ja) | 2009-02-12 |
| JP2009506044A5 true JP2009506044A5 (enExample) | 2010-04-08 |
Family
ID=37575241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008528086A Pending JP2009506044A (ja) | 2005-08-23 | 2006-08-23 | サイトカインの調節物質及び関連する使用方法 |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JP2009506044A (enExample) |
| KR (1) | KR20080041703A (enExample) |
| CN (1) | CN101291681A (enExample) |
| WO (1) | WO2007024901A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102009030351A1 (de) * | 2009-06-22 | 2010-12-23 | Gelita Ag | Zusammensetzung zur Behandlung von degenerativen Gelenkerkrankungen |
| KR101056129B1 (ko) * | 2009-12-15 | 2011-08-11 | 주식회사 엘지생활건강 | 항염증용 조성물 |
| EP2433629B1 (en) * | 2010-09-22 | 2017-11-08 | Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V. | Use of boswellic acids for the prophylaxis and/or treatment of damages and/or inflammation of the islets of Langerhans |
| CN102258191B (zh) * | 2010-12-23 | 2012-12-19 | 天津天狮生物发展有限公司 | 预防慢性炎症的抗氧化保健食品及制备方法 |
| ITMI20121570A1 (it) * | 2012-09-20 | 2014-03-21 | Indena Spa | Nuovi estratti di cynara scolimus, coffea spp. e olea europaea per il trattamento della sindrome metabolica |
| KR101944113B1 (ko) * | 2017-09-28 | 2019-01-30 | 동의대학교 산학협력단 | 급성 안면통증 예방 및 개선용 조성물 |
| TWI732147B (zh) * | 2018-10-26 | 2021-07-01 | 臺北醫學大學 | 用於抑制乙醯膽鹼酯酶之萃取物及組合物 |
| CN109907144A (zh) * | 2019-04-19 | 2019-06-21 | 陕西科技大学 | 一种具有控制血糖功效的蓝莓荨麻茶及其制备方法 |
| FR3096893B1 (fr) * | 2019-06-06 | 2022-08-05 | Laboratoire Exact | Composition a base d’extrait de jeunes pousses et utilisation pour la prevention et le traitement des maladies liees au vieillissement |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6024960A (en) * | 1998-04-17 | 2000-02-15 | Otto Torbjorn Hansen And Marianne Hansen | Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis |
| DE10153949A1 (de) * | 2000-11-07 | 2002-08-01 | Engelbert Grzeschik | Verwendung von Beerensamenölen |
| WO2005025586A1 (en) * | 2003-09-12 | 2005-03-24 | Access Business Group International Llc | Cytokine modulators and related method of use |
| AU2004273813A1 (en) * | 2003-09-12 | 2005-03-31 | Access Business Group International Llc | Program for regulating health conditions |
| US20050260290A1 (en) * | 2004-05-20 | 2005-11-24 | Rutgers, The State University Of New Jersey | Botanical anti-inflammatory compositions and methods |
-
2006
- 2006-08-23 CN CNA2006800392181A patent/CN101291681A/zh active Pending
- 2006-08-23 WO PCT/US2006/032847 patent/WO2007024901A1/en not_active Ceased
- 2006-08-23 KR KR1020087006426A patent/KR20080041703A/ko not_active Ceased
- 2006-08-23 JP JP2008528086A patent/JP2009506044A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20220902T3 (hr) | Pripravci i njihova upotreba u liječenju multiple skleroze | |
| HRP20240317T1 (hr) | Liječenje hepatičke encefalopatije uporabom rifaksimina | |
| CL2007001724A1 (es) | Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1 | |
| NO20090095L (no) | Anvendelse av en hydrofil matriks omfattende et polyakrylsyrederivat, en cellulose-eter og et disintegreringsmiddel for fremstilling av et medikament for behandling av kvinners genitale forstyrrelser | |
| MX348491B (es) | Tableta a prueba de manipulacion que proporciona liberacion inmediata de fármaco. | |
| ECSP088239A (es) | Composición de liberación de fármaco sostenida | |
| JP2010527347A5 (enExample) | ||
| MX348054B (es) | Tableta a prueba de alteracion que proporciona liberacion inmediata del farmaco. | |
| CO5190672A1 (es) | Composicion para la dosificacion oral, de disolucion instantanea | |
| JP2009538898A5 (enExample) | ||
| JP2010520246A5 (enExample) | ||
| PE20081301A1 (es) | Tabletas de bi-capa de estrogeno/moduladores selectivos de receptores de estrogeno (serm) y estrogeno/progestina | |
| WO2009002867A3 (en) | Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement | |
| JP2010525055A5 (enExample) | ||
| EA201071204A1 (ru) | Применение дронедарона для приготовления лекарственного средства для применения в предотвращении госпитализации в кардиологическое отделение или смертности | |
| JP2009506044A5 (enExample) | ||
| IL201730A (en) | History 1h - Benzaimidazole – 2 – Il – Profile – Methyl – Amino – Ethyl – 5 – Aryl – Bicyclo [2.2.2] Oct – 5 – Ann – 2 – All, Pharmaceutical preparations containing them and their use in the preparation of drugs | |
| JP2019089796A5 (enExample) | ||
| IL192611A0 (en) | Biologically active composition comprising ethylcellulose | |
| AR066924A1 (es) | Formulacion de nevirapina de liberacion prolongada | |
| WO2011141791A3 (en) | Extended release formulations of desvenlafaxine base | |
| MX2010001243A (es) | Composicion anti-inflamatoria. | |
| JP2008518699A5 (enExample) | ||
| ECSP10010683A (es) | Una formulacion farmacéutica sólida | |
| JP2009516719A5 (enExample) |